Sunshine Biopharma Files 8-K on Financials
Ticker: SBFMW · Form: 8-K · Filed: Apr 2, 2025 · CIK: 1402328
| Field | Detail |
|---|---|
| Company | Sunshine Biopharma Inc. (SBFMW) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, filing
Related Tickers: SBFM
TL;DR
Sunshine Biopharma dropped its 8-K on April 2nd detailing financial condition as of April 1st.
AI Summary
Sunshine Biopharma Inc. filed an 8-K on April 2, 2025, reporting on its Results of Operations and Financial Condition as of April 1, 2025. The filing includes financial statements and exhibits related to the company's operations.
Why It Matters
This filing provides investors with an update on Sunshine Biopharma's financial health and operational status, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Sunshine Biopharma Inc. (company) — Registrant
- April 1, 2025 (date) — Date of earliest event reported
- April 2, 2025 (date) — Filing date
- 001-41282 (company) — SEC File Number
- 20-5566275 (company) — EIN
FAQ
What specific financial information is being reported in this 8-K?
The 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
What is the exact date of the financial information reported?
The date of the earliest event reported, which is the date as of which the financial condition is being reported, is April 1, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on April 2, 2025.
What is Sunshine Biopharma Inc.'s state of incorporation?
Sunshine Biopharma Inc. is incorporated in Colorado.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 2, 2025 regarding Sunshine Biopharma Inc. (SBFMW).